CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.

The Indian Journal of Nephrology is a premier Open Access publication dedicated to advancing the field of nephrology. Published by Wolters Kluwer Medknow Publications since 2007, this journal has become a vital resource for researchers, clinicians, and students alike, providing them with a platform to disseminate innovative research findings and clinical perspectives in kidney health. With an ISSN of 0971-4065 and E-ISSN of 1998-3662, the journal plays a significant role in the dissemination of knowledge in the nephrology community, especially in India. Despite its Q3 ranking in nephrology according to the 2023 Category Quartiles, the journal reaches a diverse audience through its extensive Open Access model, promoting visibility and accessibility for all contributors. The converged years from 2009 to 2024 reflect its ongoing commitment to publishing impactful and relevant research, thus reinforcing its importance as a reliable source for the evolution of nephrological studies.

NEFROLOGIA is a preeminent scientific journal published by the SOCIEDAD ESPAÑOLA DE NEFROLOGÍA DR. RAFAEL MATESANZ, specializing in cutting-edge research and clinical advancements in the field of nephrology. Established in 1981 and continuing through 2024, this journal serves as a crucial platform for nephrologists, researchers, and healthcare professionals to disseminate knowledge and foster dialogue on critical issues affecting kidney health. With its ISSN 0211-6995 and E-ISSN 1989-2284, NEFROLOGIA is indexed in prestigious databases, ranking #35 out of 81 in the Scopus Medicine Nephrology category, reflecting its significance within the medical community. Although it does not currently offer open access, the journal ensures wide accessibility and readership through institutional subscriptions. Researchers and clinicians are invited to contribute their findings and reviews, advancing our understanding and treatment of renal diseases. Through its commitment to high scholarly standards and impactful research, NEFROLOGIA remains a vital resource for those dedicated to improving kidney care and advancing nephrology sciences.

Nature Reviews Nephrology is a prestigious academic journal published by NATURE PORTFOLIO, focusing on the rapidly evolving field of nephrology. As a leader in its category, it holds an impressive Q1 ranking in the 2023 category for Nephrology and ranks #1 out of 81 in the Scopus metrics, reflecting its high impact and relevance within the scientific community, with a staggering 99th percentile ranking. Established in 2009, this journal provides in-depth reviews, critical analysis, and cutting-edge research updates, making it an essential resource for researchers, professionals, and students alike. With an accessible Open Access policy, it enhances the dissemination of knowledge, ensuring that vital research in renal health and disease reaches a wide audience. Situated in the United Kingdom, Nature Reviews Nephrology remains committed to advancing understanding and treatment in nephrology, emphasizing the importance of this area of study in improving patient outcomes globally.

INTERNATIONAL UROLOGY AND NEPHROLOGY, published by SPRINGER, stands as a premier journal in the fields of urology and nephrology, boasting a commendable impact factor as reflected in its Q2 category rankings in both domains as of 2023. Since its inception in 1970, the journal has dedicated itself to disseminating cutting-edge research and clinical advancements that significantly impact the practice and understanding of urology and nephrology. With a Scopus rank placing it in the upper percentiles—46th out of 120 in urology and 38th out of 81 in nephrology—it offers a vital platform for researchers, healthcare professionals, and students alike to engage with high-quality, peer-reviewed articles. Although it does not operate as an open access journal, the wealth of knowledge contained within its pages remains indispensable for those committed to advancing the medical fields of urology and nephrology. The journal is located in Dordrecht, Netherlands, emphasizing its commitment to global research collaboration.

Clinical and Experimental Nephrology, published by SPRINGER, serves as a crucial platform for researchers and practitioners in the field of nephrology. With its roots dating back to 1999, the journal has made significant strides in exploring various dimensions of kidney health, thereby enriching our understanding of nephrological diseases. Aimed at fostering interdisciplinary dialogue, it covers a broad spectrum of topics from clinical practices to experimental research, evidenced by its ranked quartiles of Q2 in Nephrology and Q3 in both Physiology and Medical Physiology within its latest evaluation. Although not open access, the journal's rigorous peer-review process ensures the publication of high-quality research, making it a valuable resource for professionals, academic institutions, and students. The journal is located in Japan, with its editorial office situated at One New York Plaza, Suite 4600, New York, NY 10004, United States, reflecting its global influence and intent to disseminate critical findings in nephrology and beyond.

RENAL FAILURE is a distinguished academic journal published by TAYLOR & FRANCIS LTD, focusing on pivotal research in the fields of nephrology, critical care, and intensive care medicine. With an impact factor reflecting its significant contribution to the medical community, this open access journal has been providing a platform for peer-reviewed articles since its inception, offering free visibility to cutting-edge research since 2016. Based in the United Kingdom, RENAL FAILURE is essential for professionals, researchers, and students who seek to stay informed about the latest advancements and clinical practices in renal care. The journal’s Scopus ranking places it among the top-tier publications in its category, boasting a Q2 ranking in critical care, general medicine, and nephrology, underscoring its impactfulness in the global research landscape. Catering to a wide audience, it spans literature from 1976 through 2024, making it a cornerstone resource for anyone dedicated to enhancing the understanding and treatment of renal diseases.

The American Journal of Nephrology, published by KARGER, stands as a prestigious platform for the dissemination of high-quality research in the field of nephrology, boasting an impressive Q1 ranking in its category as of 2023. With its ISSN 0250-8095 and E-ISSN 1421-9670, the journal has been committed to advancing knowledge in kidney diseases since its inception in 1981. It serves as an essential resource for researchers, clinicians, and students alike, featuring original articles, reviews, and case reports that contribute to the understanding and treatment of renal conditions. Despite not being an open-access journal, the American Journal of Nephrology ensures a rigorous peer-review process to maintain its high academic standards, making it a vital source of information for the nephrology community worldwide. By providing insights into emerging trends and breakthroughs in kidney health, the journal continues to play a crucial role in shaping the future of nephrology research.

Jornal Brasileiro de Nefrologia is a distinguished open-access journal published by the Sociedade Brasileira de Nefrologia, catering to the dynamic field of nephrology. Since its inception, the journal has been a vital platform for disseminating cutting-edge research, clinical practices, and advancements in nephrology, particularly focusing on the Brazilian healthcare context. With an E-ISSN of 2175-8239, the journal has embraced open-access policies since 2009, promoting wider reach and accessibility for its readership. Operating out of São Paulo, Brazil, the journal holds a Q3 ranking in Nephrology as of 2023 and has contributed significantly to the academic landscape by showcasing innovative studies and discussions that shape nephrology practice. The journal not only serves as a resource for researchers but also supports nephrologists, clinicians, and students in their pursuit of knowledge, ensuring that critical developments in kidney health are shared widely. With annual publication cycles from 2010 to 2024, the Jornal Brasileiro de Nefrologia remains committed to advancing the discipline while engaging an international audience dedicated to improving patient care in nephrology.

Journal of Renal Injury Prevention, published by NIKAN RESEARCH INST, is an essential resource in the fields of nephrology and urology, catering to the growing need for specialized knowledge in the prevention and management of renal injuries. Since its establishment in 2017, this journal has worked diligently to contribute to the global discourse on renal health, exploring innovative strategies and emerging therapies. With an ISSN of 2345-2781 and an E-ISSN of 2345-2781, it aims to provide high-quality research that addresses critical aspects of kidney injuries and their prevention. While currently classified in the Q4 quartile for both nephrology and urology, the journal aspires to enhance its impact by nurturing robust discussions among researchers and clinicians alike. The journal is based in Isfahan, Iran, and welcomes submissions that advance our understanding of renal pathology. Given its commitment to the advancement of medical science, the Journal of Renal Injury Prevention is poised to play a key role in shaping future research and clinical practices in the field.